Item 2.02. Results of Operations and Financial Condition.

On August 8, 2022, Augmedix, Inc., a Delaware corporation (the "Company"), released its financial results for the second quarter ended June 30, 2022. The press release announcing the release of financial results is furnished as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On August 8, 2022, a presentation entitled "Augmedix Investor Presentation August 2022" was made available on the Presentations page of the Company's website at https://ir.augmedix.com/company-information/presentations. The presentation is furnished as Exhibit 99.2 and is incorporated herein by reference.

The information set forth in Items 2.02 and 7.01 of this Current Report on Form 8-K and in the attached Exhibits 99.1 and 99.2 are deemed to be "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information set forth in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.



Exhibit No.                                 Description
99.1            Press Release dated August 8, 2022.

99.2            Augmedix Investor Presentation August 2022.

104           Cover Page Interactive Data File--the cover page XBRL tags are embedded
              within the Inline XBRL document.




                                       1

© Edgar Online, source Glimpses